Table 1

Characteristics of patients included in studies

Ref*Age (years)Sex (%)Race (%)Follow up (months)
MeanRangeMaleFemaleAAASHSMeanRange
1145.623–7945.354.7  15 949.3/13.5/12.3 6–22
1437.425–6838.261.810015.93/14.47 9–33
2336.714–6543.856.3  22 963/16.3 1–21
15NS19–8165.434.6NRNR1.5–8
2451.825–7177.822.21008.3/8.9 4–15
  • *Recurrence definition:

  • 11=fibrovascular regrowth past limbus in area previously compromised.

  • 14=regrowth similar to original with symptoms.

  • 23=fibrovascular regrowth past limbus at least 1.5 mm with conjunctival drag.

  • 15=vascular regrowth past limbus.

  • 24=NR.

  • AA=African-American; AS=Asian; HS=Hispanic; NR=not reported.

  • Bare sclera resection group/mitomycin C group/conjunctival autograft group.

  • Bare sclera resection group/treatment group.